Synexus expands
pharmafile | July 30, 2009 | News story | Research and Development |Â Â CRO, SynexusÂ
CRO Synexus has doubled its head office capacity as it continues to grow across the UK, Central and Eastern Europe, India and South Africa.
The move into the new, modern head office premises in Chorley, Manchester, includes taking over an adjacent building and completely re-vamping the existing offices.
Part of the re-modelling process includes a new state-of-the-art Cognos IT system developed in partnership with IBM and promises to deliver significant benefits to Synexus clients right across the clinical study lifecycle.
The head office, from which Synexus manages its global network of 16 dedicated research centres, now employs some 60 staff who have helped increase the company's turnover by 60% in 2008 and are forecasting a similar increase in 2009.
Michael Fort, chief executive, said: "We are in the enviable position of continuing to enjoy robust growth during what for many are tough times. The increased capacity at our head office will support our growth and ensure we remain efficient.
"It's important to make sure our teams at head office are working in the right environment and also that we have room to grow – the re-vamped and extended offices do just that. Synexus remains a lean and efficient organisation and one which takes great pride in delivering not only first class results but also innovative solutions."
Synexus is also developing its presence in Central and Eastern Europe, having recently opened regional office in Hungary headed up by Dr Christian Tueni. The company has sites in Poland, Hungary and Bulgaria and several more are planned.
Related Content
Crown Bioscience opens new US model development centre
Crown Bioscience, a US global contract research organisation (CRO) that is part of JSR Life …
From molecule to market and beyond: Uniphar announces extended global commercialization platform
22 October 2024 – Dublin, Ireland – Healthcare services business, Uniphar, has developed its full-service …
Drug development contracts: can lessons be learned from healthcare delivery?
There is a very good question to ask at the beginning of every project: “What …
